Gossamer Bio stockholders approve 4B authorized shares, new incentive plan, and note/warrant issuance

Gossamer Bio, Inc.

Stockholders approved charter amendment increasing authorized common shares from 700M to 4B.
Stockholders approved restated 2019 Incentive Award Plan to increase shares available for issuance.
Stockholders approved potential issuance of shares upon conversion of up to $72M in new 7.50% Convertible Senior Secured First Lien Notes due 2030 and exercise of 135.8M purchase warrants.
Exchange offer for $200M 5.00% Convertible Senior Notes due 2027 closed on June 4, 2026, with new notes and warrants issued.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.